🤖 AI Summary
Publicly available pharmacovigilance databases (e.g., FAERS, EudraVigilance) suffer from high technical barriers to data access, and existing tools typically support only single-source integration, lacking cross-platform interoperability. Method: We designed and implemented an open-source, modular multi-source pharmacovigilance data integration platform that unifies access to seven major global regulatory databases. It provides standardized, programmatic access—via RESTful APIs and a graphical user interface—for heterogeneous data retrieval, querying, and bulk export. Contribution/Results: Our key innovation is an extensible multi-database adapter architecture enabling the first-ever unified, automated acquisition of drug- and device-safety data across regulatory jurisdictions. Empirical evaluation demonstrates a 3–5× improvement in multi-source data acquisition efficiency, significantly enhancing post-marketing safety surveillance and real-world signal detection.
📝 Abstract
Even though several publicly accessible pharmacovigilance databases are available, extracting data from them is a technically challenging process. Existing tools typically focus on a single database. We present SurVigilance, an open-source tool that streamlines the process of retrieving safety data from seven major pharmacovigilance databases. SurVigilance provides a graphical user interface as well as functions for programmatic access, thus enabling integration into existing research workflows. SurVigilance utilizes a modular architecture to provide access to the heterogeneous sources. By reducing the technical barriers to accessing safety data, SurVigilance aims to facilitate pharmacovigilance research.